Michael P. Dube

Insider Reports History

Entity: Individual
Location: C/O Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge, MA
Signature: James Basta, attorney-in-fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael P. Dube:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Intellia Therapeutics, Inc.	VP, Chief Accounting Officer	Common Stock	59.6K	$536K	$8.99	Mar 1, 2025	Direct

Showing 1 to 1 of 1 entries

Insider Reports Filed by Michael P. Dube

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
NTLA	Intellia Therapeutics, Inc.	Mar 1, 2025	1	$0	4	Mar 4, 2025	VP, Chief Accounting Officer
NTLA	Intellia Therapeutics, Inc.	Jan 3, 2025	1	-$16.7K	4	Jan 7, 2025	VP, Chief Accounting Officer
NTLA	Intellia Therapeutics, Inc.	Oct 2, 2024	1	-$38.2K	4	Oct 4, 2024	VP, Chief Accounting Officer
NTLA	Intellia Therapeutics, Inc.	Jul 1, 2024	1	$0	4	Jul 3, 2024	VP, PAO and Interim PFO
NTLA	Intellia Therapeutics, Inc.	Apr 10, 2024	0	$0	3	Apr 22, 2024	Principal Accounting Officer